Quantum Financial Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Quantum Financial Partners's XBI Position: Q3 2026 in Review
Quantum Financial Partners increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.1% in Q3 2026, buying an estimated $7.58K and bringing the position to 1,616 shares worth $255K. The position accounts for 0.13% of the portfolio, ranked #131.
Quantum Financial Partners first reported a position in XBI in Q2 2026 and has held it in 2 quarters since. 734 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Quantum Financial Partners held 1,616 shares of State Street SPDR S&P Biotech ETF worth $255K as of Q3 2026.
- Quantum Financial Partners bought 48 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $7.58K.
- State Street SPDR S&P Biotech ETF made up 0.13% of Quantum Financial Partners's portfolio in Q3 2026, its #131 holding.
- Quantum Financial Partners first reported a position in State Street SPDR S&P Biotech ETF in Q2 2026 and has held it in 2 quarters since.
- 734 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Quantum Financial Partners's 13F filing for Q3 2026, filed 19 Oct 2026.